National Health Investors Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

National Health Investors hat ein Gesamteigenkapital von $1.3B und eine Gesamtverschuldung von $1.1B, wodurch sich der Verschuldungsgrad auf 89.9% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $2.5B bzw. $1.2B. National Health Investors Das EBIT des Unternehmens beträgt $177.4M, so dass der Zinsdeckungsgrad 3 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $11.4M.

Wichtige Informationen

89.9%

Verhältnis von Schulden zu Eigenkapital

US$1.14b

Verschuldung

Zinsdeckungsgrad	3x
Bargeld	US$11.36m
Eigenkapital	US$1.27b
Gesamtverbindlichkeiten	US$1.21b
Gesamtvermögen	US$2.48b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

National Health Investors Q2 Earnings Preview

Aug 07

National Health Investors: A 5.8% Yield, And Little Else

Jun 29

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Apr 14

National Health Investors: Why This 7% Yielder Is A Buy On The Drop

Feb 06

National Health Management Believes The 6.4% Yield Is Sustainable

Nov 17

National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment

Oct 11

National Health Investors: Buy 'Em When They're Cheap

Sep 26

National Health Investors: The Most Bearish Bull Thesis I Hope To Ever Write

Aug 31

National Health: Not Out Of The Woods Yet

Aug 10

National Health Investors reaches deferral agreement with Bickford

Jun 17

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NHIDie kurzfristigen Aktiva des Unternehmens ($116.7M) decken seine kurzfristigen Passiva ($141.3M) nicht.

Langfristige Verbindlichkeiten: NHIDie kurzfristigen Vermögenswerte des Unternehmens ($116.7M) decken seine langfristigen Verbindlichkeiten ($1.1B) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NHIDie Nettoverschuldung im Verhältnis zum Eigenkapital (89%) wird als hoch angesehen.

Schulden abbauen: NHI Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 90.9% auf 89.9% zurückgegangen.

Schuldendeckung: NHIDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (17%) gedeckt.

Zinsdeckung: NHIDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (3x Coverage) gut gedeckt.

National Health Investors Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

Consensus EPS estimates fall by 21%

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Chief Investment Officer exercised options and sold US$220k worth of stock

Price target increased to US$62.71

Independent Director recently bought US$99k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

National Health Investors Q2 Earnings Preview

National Health Investors, Inc. to Report Q2, 2022 Results on Aug 08, 2022

National Health Investors: A 5.8% Yield, And Little Else

Upcoming dividend of US$0.90 per share

Consensus forecasts updated

National Health Investors, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

An unknown buyer acquired Two Assisted Living Facilities Located in Texas from National Health Investors, Inc. (NYSE:NHI) for $7.8 million.

National Health Investors, Inc. to Report Q1, 2022 Results on May 09, 2022

National Health Investors, Inc. (NYSE:NHI) announces an Equity Buyback for $240 million worth of its shares.

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Discovery Senior Living and National Health Investors, Inc. (NYSE:NHI) acquired 9-Community Independent Living Portfolio from Holiday AL Management Sub LLC.

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Declares First Quarter Dividend, Payable on May 6

An unknown buyer acquired Medical Office Building Located in Texas fromNational Health Investors, Inc. (NYSE:NHI) for approximately $5.1 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors: Why This 7% Yielder Is A Buy On The Drop

National Health Investors, Inc. to Report Q4, 2021 Results on Feb 22, 2022

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$156k worth of stock

National Health Management Believes The 6.4% Yield Is Sustainable

Third quarter 2021 earnings released: FFO US$1.17 per share (vs US$1.42 in 3Q 2020)

National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment